Core Viewpoint - The article discusses allegations of potential fraud regarding the collagen content in a product from Juzhibio, specifically questioning the accuracy of the ingredient labeling and the detection methods used to measure collagen levels [1][2]. Group 1: Allegations and Testing - A social media influencer raised concerns about the collagen content in Juzhibio's product, claiming that the detected amount of collagen was significantly lower than what was stated on the label [1][2]. - The influencer used high-precision HPLC amino acid quantification methods and reported that the detected collagen content was only 0.0177%, while the product label suggested that collagen should be present in amounts greater than 0.1% [2]. - The influencer highlighted that glycine, a key amino acid in collagen, was not detected in the sample, which contradicts established knowledge that glycine constitutes one-third of collagen's amino acid residues [2]. Group 2: Company Response - In response to the allegations, Juzhibio's brand, Kefu Mei, issued a statement asserting that multiple tests conducted in accordance with industry standards showed collagen content exceeding 0.1% [5][7]. - The company provided testing results from five samples taken on May 24, showing collagen levels of 0.27% to 0.28% [7]. - Kefu Mei criticized the influencer's testing methods as not being recognized by industry standards and claimed that the influencer did not request the original collagen raw materials for testing [9]. Group 3: Background and Financial Performance - Juzhibio, known as the "first stock of recombinant collagen," has rapidly grown to become the largest beauty and skincare company in Hong Kong by market capitalization, reaching HKD 82.1 billion as of May 23 [11]. - The company's revenue for 2024 was reported at CNY 5.539 billion, reflecting a year-on-year growth of 57.17%, while net profit reached CNY 2.062 billion, up 42.06% [14]. - The founders of Juzhibio recently became the richest individuals in Shaanxi province, with a combined stock value exceeding CNY 45 billion [13].

Core Viewpoint - The beauty blogger "Dr. Big Mouth" accused Giant Biological (02367.HK) of serious fraud regarding its Kefu Mei collagen essence, claiming that the actual content of recombinant collagen is only 0.0177% in the best-selling product, and that the key component "glycine" is missing [2][3][10]. Group 1: Accusations and Responses - The blogger questioned the legality of labeling recombinant collagen as a non-trace component when its actual content is below the regulatory threshold of 0.1% [3][10]. - Giant Biological issued a statement firmly denying the allegations, asserting that multiple tests showed collagen content greater than 0.1%, contradicting the blogger's claims [12][14]. - The company emphasized its adherence to scientific ethics and regulatory compliance, stating that all products are rigorously tested and verified [12][14]. Group 2: Product Composition Concerns - The blogger raised concerns about the absence of glycine in a product claiming to contain recombinant collagen, questioning the validity of calling it "recombinant collagen" [5][9]. - There were also questions about the marketing of a dipeptide molecule as "Mini small molecule collagen," suggesting potential misuse of scientific terminology [7]. Group 3: Market Performance and Investor Sentiment - Despite the controversies, Giant Biological has seen significant growth, reporting a revenue of 5.539 billion yuan in 2024, a year-on-year increase of 57.07%, and a net profit of 2.062 billion yuan, up 42.06% [22]. - The company has gained substantial attention from investors, with several funds heavily investing in its stock, indicating strong market confidence [24].

Core Viewpoint - The article discusses allegations against Juzhi Biotechnology regarding potential falsification of collagen content in their product, specifically the "Human-Like Recombinant Collagen" serum, following a social media post by a blogger who claims to have conducted tests revealing significantly lower collagen levels than stated on the product label [1][2]. Group 1: Allegations and Testing - A social media influencer conducted tests using high-precision HPLC methods and reported that the detected collagen content was only 0.0177%, which raises questions about the accuracy of the product's ingredient label [1][2]. - The blogger highlighted that the product's ingredient list includes "soluble collagen" as a primary component, which should be above 0.1% according to cosmetic labeling regulations, yet the test results suggest otherwise [2]. - The absence of glycine, a key amino acid in collagen, in the test results further supports the allegations of misrepresentation [2]. Group 2: Company Response - Juzhi Biotechnology's brand, Kefu Mei, issued a statement claiming that multiple tests conducted in accordance with industry standards showed collagen content exceeding 0.1%, with specific results of 0.27%, 0.27%, and 0.28% from samples taken on May 24 [5][8]. - The company criticized the blogger's testing methods as not being recognized by industry standards and stated that the blogger did not request the original collagen material for testing [9]. - Kefu Mei announced plans to engage multiple authoritative third-party testing agencies for further verification of their products [9]. Group 3: Background and Market Position - Juzhi Biotechnology, known for its brands Kefu Mei and Keli Jin, has become the largest beauty and skincare company in Hong Kong by market capitalization, reaching HKD 82.1 billion as of May 23 [13]. - The company reported a revenue of CNY 5.539 billion for 2024, reflecting a year-on-year growth of 57.17%, with a net profit of CNY 2.062 billion, up 42.06% [15]. - The founder of Juzhi Biotechnology recently became the richest person in Shaanxi province, with a stock value exceeding CNY 450 billion [15].

Core Viewpoint - A social media influencer raised concerns about potential fraud by Juzhi Biotechnology regarding their collagen product, claiming that the detected collagen content was significantly lower than what was stated on the product label [2][3]. Group 1: Detection and Analysis - The influencer utilized high-precision HPLC amino acid quantification methods to test the collagen product, revealing that the detected collagen content was only 0.0177%, which is below the expected threshold of 0.1% for non-trace ingredients [2][3]. - The influencer's analysis indicated that glycine, a key component of collagen, was not detected in the sample, contradicting established knowledge that glycine constitutes one-third of collagen's amino acid residues [3]. Group 2: Company Response - In response to the allegations, Juzhi Biotechnology's brand Kefu Mei stated that their own testing showed collagen content exceeding 0.1%, with results of 0.27%, 0.27%, and 0.28% from multiple samples taken on May 24 [4]. - The company criticized the influencer's testing methods as not being recognized by industry standards and claimed that the influencer did not request the original collagen material for testing [4]. Group 3: Regulatory Context - A consumer previously reported adverse effects after using a product from Juzhi Biotechnology, leading to a separate investigation regarding the presence of epidermal growth factor (EGF), which is prohibited in cosmetics [4][5]. - The Shaanxi Provincial Drug Administration conducted inspections and found no evidence of EGF in the products, concluding that the company did not engage in illegal practices regarding EGF [5].